FLGT - Fulgent Genetics Inc. (FLGT) CEO Ming Hsieh on Q2 2021 Results - Earnings Call Transcript
Fulgent Genetics, Inc. (FLGT) Q2 2021 Earnings Conference Call August 09, 2021 04:30 PM ET Company Participants Nicole Borsje - Investor Relations Ming Hsieh - Chief Executive Officer Larry Weiss - Chief Medical Officer Brandon Perthuis - Chief Commercial Officer Paul Kim - Chief Financial Officer Conference Call Participants Kevin DeGeeter - Oppenheimer Steven Mah - Piper Sandler Katie Tryhane - Crédit Suisse Presentation Operator Good day, and welcome to the Fulgent Genetics 2Q 2021 Earnings Conference Call. At this time, I would like to turn the conference over to Nicole Borsje with Investor Relations. Please go ahead. Nicole Borsje Great. Thanks. Good afternoon, and welcome to the Fulgent Genetics Second Quarter 2021 Financial Results Conference Call. On the call today are Ming Hsieh, Chief Executive Officer; Paul Kim, Chief Financial Officer; Dr. Larry Weiss, Chief Medical Officer; and Brandon Perthuis, the company's Chief Commercial Officer. The company's press release
For further details see:
Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q2 2021 Results - Earnings Call Transcript